Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Inventory: 2017-2025

Historic Inventory for RedHill Biopharma (RDHL) over the last 7 years, with Jun 2025 value amounting to $3.2 million.

  • RedHill Biopharma's Inventory fell 16.69% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year decrease of 16.69%. This contributed to the annual value of $3.7 million for FY2024, which is 16.81% down from last year.
  • RedHill Biopharma's Inventory amounted to $3.2 million in Q2 2025, which was down 13.20% from $3.7 million recorded in Q4 2024.
  • RedHill Biopharma's 5-year Inventory high stood at $14.3 million for Q1 2022, and its period low was $3.2 million during Q2 2025.
  • Over the past 3 years, RedHill Biopharma's median Inventory value was $4.1 million (recorded in 2023), while the average stood at $4.3 million.
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 235.02% in 2021, then plummeted by 60.13% in 2023.
  • Over the past 5 years, RedHill Biopharma's Inventory (Quarterly) stood at $7.7 million in 2021, then spiked by 42.97% to $11.0 million in 2022, then plummeted by 60.13% to $4.4 million in 2023, then dropped by 16.81% to $3.7 million in 2024, then decreased by 16.69% to $3.2 million in 2025.
  • Its Inventory was $3.2 million in Q2 2025, compared to $3.7 million in Q4 2024 and $3.8 million in Q2 2024.